Human leukocyte antigen-G (HLA-G) expression in cervical lesions: Association with cancer progression, HPV 16/18 infection, and host immune response

Reproductive Sciences

Volumn 17, Issue 8, 2010, Pages 718-723

  Dong, Dan Dan ^a   Hong Yang, ^a   Ke Li, ^a   Gang Xu, ^a   Song, Lin Hong ^a   Fan, Xiao Li ^a   Jiang, Xin Lian ^a   Yie, Shang Mian ^a  

^a SICHUAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

cervical cancer; CIN; HLA G; HPV; TIL

Indexed keywords

CD57 ANTIGEN; HLA G ANTIGEN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VIRUS INFECTION;

ADULT; AGED; AGED, 80 AND OVER; CERVICAL INTRAEPITHELIAL NEOPLASIA; DISEASE PROGRESSION; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; IMMUNITY, CELLULAR; LYMPHOCYTES, TUMOR-INFILTRATING; MIDDLE AGED; NEOPLASMS, SQUAMOUS CELL; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 77954339619     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719110369183     Document Type: Article

References (29)

1. Pisani P., Bray F., Parkin DM Estimates of the worldwide prevalence of cancer for 25 sites in the adult population. Int J Cancer. 2002 ; 97 (1). 72-81.
2. Burd, EM Human Papillomavirus and Cervical Cancer. Clin Microbiol Rev. 2003 ; 16 (1). 1-17.
3. Vermeulen CFW, Ekaterina S., Jordanova ES, et al. Frequent HLA Class I loss is an early event in cervical carcinogenesis. Hum Immunol. 2005 ; 66 (11). 1167-1173.
4. Hicklin DJ, Marincola FM, Ferrone S. HLA class I antigen down-regulation in human cancers: T-cell immunotherapy revives an old story. Mol Med Today. 1999 ; 5 (4). 178-186.
5. Goncalves MA, Le Discorde M., Simoes RT, et al. Classical and non-classical HLA molecules and p16(INK4a) expression in precursors lesions and invasive cervical cancer. Eur J Obstet Gynecol Reprod Biol. 2008 ; 141 (1). 70-74.
6. Zhou JH, Ye F., Chen HZ, Zhou CY, Lu WG, Xie X. Altered expression of cellular membrane molecules of HLA-DR, HLA-G and CD99 in cervical intraepithelial neoplasias and invasive squamous cell carcinoma. Life Sci. 2006 ; 78 (22). 2643-2649.
7. Yoon BS, Kim YT, Kim JW, Kim SH, Kim JH, Kim SW Expression of human leukocyte antigen-G and its correlation with interleukin-10 expression in cervicalcarcinoma. Int J Gyn Obs. 2007 ; 98 (1). 48-53.
8. Guimarà£es MCM, Soares CP, Donadi EA, et al. Low expression of human histocompatibility soluble leukocyte antigen G (HLA-5) in invasive cervical cancer with and without metastasis, associated with papilloma virus (HPV) [Epub ahead of print.]. J Hist Cytochem. 2009 ; DOI: 10.1369/jhc.2009. 954131.
9. Carosella ED, Moreau P., Lemaoult J., Rouas-Freiss N. HLA-G: from biology to clinical benefits. Trends Immunol. 2008 ; 29 (3). 125-132.
10. Urosevic MJ, Dummer R. Human Leukocyte Antigen-G and Cancer Immunoediting. Cancer Res. 2008 ; 68 (3). 627-630.
11. Onno M., Pangault C., Le Friec G., Guilloux V., Andre P., Fauchet R. Modulation of HLA-G antigens expression by human cytomegalovirus: specific induction in activated macrophages harboring human cytomegalovirus infection. J Immunol. 2000 ; 164 (12). 6426-6434.
12. Lozazo JM, Gonzalez R., Kindelan JM, et al. Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule. AIDS. 2002 ; 16 (3). 347-351.
13. Lafon M., Prehaud C., Megret F., et al. Modulation of HLA-G expression in human neural cells after neurotropic viral infections. J Virol. 2005 ; 79 (24). 15226-15237.
14. de Oliveira CF, Mota F. Cervical cancer-pre-therapeutic investigations and clinical staging versus surgical staging. CME J Gynecol Oncol. 2001 ; 6: 246-256.
15. Ye SR, Yang H., Li K., Dong DD, Lin XM, Yie SM Human leukocyte antigen G expression: as a significant prognostic indicator for patients with colorectal cancer. Mod Pathol. 2007 ; 20 (3). 375-383.
16. Yie SM, Yang H., Ye SR, Li K., Dong DD, Lin XM Expression of HLA-G is associated with prognosis in esophageal squamous cell carcinoma. Am J Clin Pathol. 2007 ; 128 (6). 1002-1009.
17. Yie SM, Yang H., Ye SR, Li K., Dong DD, Lin XM Expression of human leucocyte antigen G (HLA-G) is associated with prognosis in non-small cell lung cancer. Lung Cancer. 2007 ; 58 (2). 267-274.
18. Yie SM, Yang H., Ye SR, Li K., Dong DD, Lin XM Expression of human leukocyte antigen G (HLA-G) correlates with poor prognosis in gastric carcinoma. Ann Surg Oncol. 2007 ; 14 (10). 2721-2729.
19. He X., Dong DD, Yie SM, et al. HLA-G expression in human breast cancer: implications for diagnosis and prognosis, and effect on allo-cytotoxic lymphocyte response after hormone treatment in vitro [Epub ahead of print.]. Ann Surg Oncol. 2009 ; DOI: 10.1245/s10434-009-0891-9.
20. Walboomers JMM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999 ; 189 (1). 12-19.
21. Jung YW, Kim YT, Kim SW, et al. Correlation of human leukocyte antigen-G (HLA-G) expression and disease progression in epithelial ovarian cancer. Reproductive Sciences. 2009 ; 16 (11). 1103-1111.
22. Barrier BF, Kendall BS, Sharpe-Timms KL, Kost WR Characterization of human leukocyte antigen-G (HLA-G) expression in endometrial adenocarcinoma. Gynecol Oncol. 2006 ; 103 (1). 25-30.
23. Lin A., Chen HX, Zhu CC, et al. Aberrant human leukocyte antigen-G expression and its clinical relevance in hepatocellular carcinoma. J Cell Mol Med. 2009 Oct 3. [Epub ahead of print].
24. Kanodia S., Fahey LM, Kast WM Mechanisms used by human papillomaviruses to escape the host immune response. Current cancer targets. 2007 ; 7 (1). 79-89.
25. Hildesheim A., Wang SS Host and viral genetics and risk of cervical cancer: a review. Virus Res. 2002 ; 89 (2). 229-240.
26. Simoes RT, Goncalves MA, castelli EC, et al. HLA-G polymorphisms in women with squamous intraepithelial lesions harboring human papillomavirus. Mod Pathol. 2009 ; 22 (8). 1075-1082.
27. Galon J., Costes A., Sanchez-Cabo F., et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 2006 ; 313 (5795). 1960-1964.
28. Cai MY, Xu YF, Qiu SJ, et al. Human leukocyte antigen-G protein expression is an unfavorable prognostic predictor of hepatocellular carcinoma following curative resection. Clin Cancer Res. 2009 ; 15 (14). 4686-4693.
29. Cutts FT, Franceschi S., Goldie S., et al. Human papillomavirus and HPV vaccines: a review. Bull World Health Organ. 2007 ; 85 (9). 719-726.